


Searching News Database: Edge Systems
HSMN NewsFeed - 31 Aug 2018
Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America
Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America
HSMN NewsFeed - 6 Mar 2018
Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs
Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs
HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
HSMN NewsFeed - 1 Dec 2017
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
HSMN NewsFeed - 24 Oct 2017
First Patients in US Treated with Varian HyperArc High Definition Radiotherapy
First Patients in US Treated with Varian HyperArc High Definition Radiotherapy
HSMN NewsFeed - 23 Oct 2017
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
HSMN NewsFeed - 13 Jan 2017
Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration Partnership
Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration Partnership
HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
HSMN NewsFeed - 7 Dec 2010
Wright Medical Group, Inc. Announces Initial Release of the PRO-TOE(TM) VO Hammertoe Fixation System
Wright Medical Group, Inc. Announces Initial Release of the PRO-TOE(TM) VO Hammertoe Fixation System
HSMN NewsFeed - 18 Nov 2009
Wright Medical Group, Inc. Announces Initial Release of the VALOR Ankle Fusion Nail System
Wright Medical Group, Inc. Announces Initial Release of the VALOR Ankle Fusion Nail System
HSMN NewsFeed - 17 Aug 2009
Wright Medical Group, Inc. Introduces CORETRAK Articulating External Fixator for Foot Surgery
Wright Medical Group, Inc. Introduces CORETRAK Articulating External Fixator for Foot Surgery
HSMN NewsFeed - 24 Apr 2007
New TNS(R) Serum From SkinMedica(R) Exclusively Applied Through HydraFacial MD(TM) by Edge Systems
New TNS(R) Serum From SkinMedica(R) Exclusively Applied Through HydraFacial MD(TM) by Edge Systems
Additional items found! 2
Members Archive contains
2 additional stories matching:
Edge Systems
(Password required)
Edge Systems
(Password required)
